University of Chicago, Section of Endocrinology, Diabetes, and Metabolism, Chicago, Illinois.
Carleton College, Northfield, Minnesota.
Endocr Pract. 2022 Mar;28(3):257-264. doi: 10.1016/j.eprac.2021.12.003. Epub 2021 Dec 8.
Patient-centered studies have shown that several patients on thyroid hormone replacement therapy for hypothyroidism exhibit persistent symptoms, including "brain fog." Here, we aimed to determine which of these specific symptoms are associated with brain fog, identify patient-reported factors that modify these symptoms, and identify patient concerns related to brain fog not included in thyroid-specific questionnaires.
A survey on brain fog symptoms adapted from thyroid-specific patient-reported outcome was distributed online. Textual data analysis was performed to identify common areas of concern from open-ended survey responses.
A total of 5170 participants reporting brain fog while being treated for hypothyroidism were included in the analysis. Of these, 2409 (46.6%) participants reported symptom onset prior to the diagnosis of hypothyroidism, and 4096 (79.2%) participants experienced brain fog symptoms frequently. Of the symptoms listed, participants associated fatigue and forgetfulness most frequently with brain fog. More rest was the most common factor provided for improving symptoms. The textual data analysis identified areas of concern that are not often included in thyroid-specific quality of life questionnaires, including a focus on the diagnosis of hypothyroidism, the types and doses of medications, and the patient-doctor relationship.
Brain fog in patients treated for hypothyroidism was associated most frequently with fatigue and cognitive symptoms. Several additional areas of patient concern were found to be associated with brain fog, which are not typically addressed in thyroid-specific questionnaires.
以患者为中心的研究表明,一些接受甲状腺激素替代治疗的甲状腺功能减退症患者持续存在多种症状,包括“脑雾”。在此,我们旨在确定这些特定症状中哪些与脑雾有关,确定可改变这些症状的患者报告因素,并确定与甲状腺特异性问卷中未包含的脑雾相关的患者关注点。
我们在线上发布了一项针对甲状腺特异性患者报告结果的脑雾症状调查问卷。我们对文本数据进行了分析,以确定来自开放式调查回复中的常见关注点。
共有 5170 名报告甲状腺功能减退症治疗期间存在脑雾的参与者纳入了分析。其中,2409 名(46.6%)参与者报告在诊断为甲状腺功能减退症之前出现症状,4096 名(79.2%)参与者经常出现脑雾症状。在所列出的症状中,参与者最常将疲劳和健忘与脑雾联系起来。改善症状最常用的方法是多休息。文本数据分析确定了一些通常不包含在甲状腺特异性生活质量问卷中的关注点,包括对甲状腺功能减退症的诊断、药物类型和剂量以及医患关系的关注。
接受甲状腺功能减退症治疗的患者的脑雾与疲劳和认知症状最相关。还发现了一些与脑雾相关的其他患者关注点,这些关注点通常未在甲状腺特异性问卷中得到解决。